My name is Oleksandr, I am a medical doctor and researcher. Here (clickable) you will find more information about me, including a short biography, social media links, and CV.
You are now on my blog, dedicated to rare diseases and omics. Swipe down to see the recent publications and the projects I’m currently involved in.
This website is available in English (you are here) and Ukrainian languages. Enjoy, and don’t hesitate to contact me!
“Breaking news! Share urgently! WHO officially stated that drug X should/shouldn’t be administered in COVID-19!” — you could have read online in the last few days. While humanity is on the way to overcome the pandemic infection, it seems that another evil spreads its vile roots, and its name is false and unproven news.
Proteomic assay for Fabry disease Fabry disease (FD) is an X-linked glycosphingolipid lysosomal storage disorder, which affects approximately 1 in 40 000 – 117 000 males. Female patients may have different manifestations of the disease, although its prevalence in females is unknown.
Cystic fibrosis is a genetic disease, the cause of which is the presence of pathological variants of both copies of CFTR gene. The CFTR protein is a channel, which transfers chloride ions.
I am reading the infectious disease surveillance data with a certain watchfulness, to be prepared better to face the disease in patients, friends, family. A few years ago my country was at risk to import the Ebola virus disease and in 2016 two cases of Zika virus infection were proved near us, in Poland.
The survival of tumor cells depends both on their own characteristics and on the parameters of the microenvironment, which consists of vessels, cells of the immune system, connective tissue components and the extracellular matrix, nerve and endocrine cells may also be present.